Cargando…
Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS
OBJECTIVE: To assess the safety of ocrelizumab (OCR) shorter duration infusion in patients with MS. METHODS: ENSEMBLE PLUS is a randomized, double-blind substudy to the single-arm ENSEMBLE study (NCT03085810). In ENSEMBLE, patients with early stage relapsing-remitting MS received OCR 600 mg initiall...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286651/ https://www.ncbi.nlm.nih.gov/pubmed/32503093 http://dx.doi.org/10.1212/NXI.0000000000000807 |